3 Months progress on Fin, min and microneedling
    Progress Pictures 4/13/2025

    From the encyclopedia
    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Minoxidil →

    An essential vasodilator with some anti-androgenic effects

    Microneedling →

    technique to create small wounds in skin to activate collagen production and hair growth

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg 1x daily 3 months
    💧 Minoxidil (topical) 5% 1x daily 3 months
    Microneedling (dermaroller) 1.5 mm 2x weekly 3 months
    the tone is 😀 positive with incredible progress results.

    Other terms

    A user shared their 3-month hair growth progress using 1mg oral finasteride, 5% topical minoxidil, and microneedling with a 1.5 mm dermaroller twice weekly. The user received positive feedback and expressed a desire for thicker hair in the future.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Microneedling for the Treatment of Hair Loss

      research Microneedling for the treatment of hair loss?

      58 citations , December 2017 in “Journal of The European Academy of Dermatology and Venereology”
      This review highlights that microneedling shows some promise for improving hair growth in alopecia, particularly when used with other treatments, though more research is needed to establish its efficacy and protocols.

      research Microneedling for androgenetic alopecia not responding to conventional treatment

      3 citations , March 2020 in “Our Dermatology Online”
      In this case series from Nepal, microneedling in combination with oral finasteride and minoxidil was associated with moderate to significant hair growth improvement in androgenetic alopecia patients, with high satisfaction and no complications reported.
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
      A Decade of Progress in Androgenetic Alopecia Management: Emerging Therapies and Multimodal Strategies

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
      The Rise of Transcutaneous Drug Delivery for the Management of Alopecia: A Review of Existing Literature and an Eye Towards the Future

      research The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future

      9 citations , October 2018 in “Journal of Cosmetic and Laser Therapy”
      This study reviewed eight studies investigating transcutaneous drug delivery via fractional laser and microneedling for alopecia treatment, with six studies showing improved hair regrowth over topical therapy alone, suggesting its potential as a promising treatment strategy, although further research is needed to refine treatment parameters.